{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:54:29Z","timestamp":1793836469621,"version":"4.6.1"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS090904"],"award-info":[{"award-number":["NS090904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS117827"],"award-info":[{"award-number":["NS117827"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL142975"],"award-info":[{"award-number":["HL142975"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["16 CVD 05"],"award-info":[{"award-number":["16 CVD 05"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>\n                    Pericytes, mural cells of brain capillaries, maintain the blood-brain barrier (BBB), regulate cerebral blood flow (CBF), and protect neurons against ischemic damage. To further investigate the role of pericytes in ischemia, we induced stroke by 45-min transient middle cerebral artery occlusion (tMCAo) in 6-month-old pericyte-deficient\n                    <jats:italic>Pdgfrb<\/jats:italic>\n                    <jats:sup>+ \u2063\/\u2212<\/jats:sup>\n                    mice and control\n                    <jats:italic>\n                      Pdgfrb\n                      <jats:sup>+\/+<\/jats:sup>\n                    <\/jats:italic>\n                    littermates. Compared to controls,\n                    <jats:italic>Pdgfrb<\/jats:italic>\n                    <jats:sup>+ \u2063\/\u2212<\/jats:sup>\n                    mice showed a 26% greater loss of CBF during early reperfusion, and 40\u201350% increase in the infarct and edema volumes and motor neurological score 24 h after tMCAo. These changes were accompanied by 50% increase in both immunoglobulin G and fibrinogen pericapillary deposits in the ischemic cortex 8 h after tMCAo indicating an accelerated BBB breakdown, and 35 and 55% greater losses of pericyte coverage and number of degenerating neurons 24 h after tMCAo, respectively. Treatment of\n                    <jats:italic>Pdgfrb<\/jats:italic>\n                    <jats:sup>+ \u2063\/\u2212<\/jats:sup>\n                    mice with 3K3A-activated protein C (APC), a cell-signaling analog of plasma protease APC, administered intravenously 10 min and 4 h after tMCAo normalized CBF during the early reperfusion phase and reduced infarct and edema volume and motor neurological score by 55\u201360%, with similar reductions in BBB breakdown and number of degenerating neurons. Our data suggest that pericyte deficiency results in greater brain injury, BBB breakdown, and neuronal degeneration in stroked mice and that 3K3A-APC protects the brain from accelerated injury caused by pericyte deficiency. These findings may have implications for treatment of ischemic brain injury in neurological conditions associated with pericyte loss such as those seen during normal aging and in neurodegenerative disorders such as Alzheimer\u2019s disease.\n                  <\/jats:p>","DOI":"10.3389\/fnins.2022.841916","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T08:05:46Z","timestamp":1648627546000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["3K3A-Activated Protein C Protects the Blood-Brain Barrier and Neurons From Accelerated Ischemic Injury Caused by Pericyte Deficiency in Mice"],"prefix":"10.3389","volume":"16","author":[{"given":"Yaoming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassandra","family":"Kisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki Maria","family":"Nikolakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berislav V.","family":"Zlokovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuropharm.2017.09.021","article-title":"Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C.","volume":"134","author":"Amar","year":"2018","journal-title":"Neuropharmacology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood-brain barrier.","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.neuron.2010.09.043","article-title":"Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.","volume":"68","author":"Bell","year":"2010","journal-title":"Neuron"},{"key":"B4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1161\/STROKEAHA.109.551341","article-title":"Severe blood-brain barrier disruption and surrounding tissue injury.","volume":"40","author":"Chen","year":"2009","journal-title":"Stroke"},{"key":"B6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00401-018-1893-0","article-title":"Targeting pericytes for therapeutic approaches to neurological disorders.","volume":"136","author":"Cheng","year":"2018","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nature09513","article-title":"Pericytes are required for blood-brain barrier integrity during embryogenesis.","volume":"468","author":"Daneman","year":"2010","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/bpa.12888","article-title":"Loss of capillary pericytes and the blood-brain barrier in white matter in poststroke and vascular dementias and Alzheimer\u2019s disease.","volume":"30","author":"Ding","year":"2020","journal-title":"Brain Pathol. Zurich Switz."},{"key":"B9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/jcbfm.2012.187","article-title":"Early loss of pericytes and perivascular stromal cell-induced scar formation after stroke.","volume":"33","author":"Fern\u00e1ndez-Klett","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1126\/science.1203165","article-title":"A pericyte origin of spinal cord scar tissue.","volume":"333","author":"G\u00f6ritz","year":"2011","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0271678X16671146","article-title":"The capillary bed offers the largest hemodynamic resistance to the cortical blood supply.","volume":"37","author":"Gould","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1182\/blood-2015-02-355974","article-title":"Activated protein C: biased for translation.","volume":"125","author":"Griffin","year":"2015","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood-2018-02-769026","article-title":"Activated protein C, protease activated receptor 1, and neuroprotection.","volume":"132","author":"Griffin","year":"2018","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1460-9568.2009.06664.x","article-title":"Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity.","volume":"29","author":"Guo","year":"","journal-title":"Eur. J. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1471-4159.2009.05921.x","article-title":"Species-dependent neuroprotection by activated protein C mutants with reduced anticoagulant activity.","volume":"109","author":"Guo","year":"","journal-title":"J. Neurochem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1523\/JNEUROSCI.4491-12.2013","article-title":"An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway.","volume":"33","author":"Guo","year":"2013","journal-title":"J. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00784-4","article-title":"Iptakalim improves cerebral microcirculation in mice after ischemic stroke by inhibiting pericyte contraction.","author":"Guo","year":"2021","journal-title":"Acta Pharmacol. Sin"},{"key":"B18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature13165","article-title":"Capillary pericytes regulate cerebral blood flow in health and disease.","volume":"508","author":"Hall","year":"2014","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/jcbfm.2015.44","article-title":"Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer\u2019s disease.","volume":"36","author":"Halliday","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41593-020-00793-2","article-title":"Brain capillary pericytes exert a substantial but slow influence on blood flow.","volume":"24","author":"Hartmann","year":"2021","journal-title":"Nat. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e20211372","DOI":"10.1084\/jem.20211372","article-title":"Protection of ischemic white matter and oligodendrocytes in mice by 3K3A-activated protein C.","volume":"219","author":"Huuskonen","year":"2022","journal-title":"J. Exp. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.","volume":"18","author":"Kisler","year":"","journal-title":"Nat. Rev. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nn.4489","article-title":"Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain.","volume":"20","author":"Kisler","year":"","journal-title":"Nat. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fncel.2020.00027","article-title":"Acute ablation of cortical pericytes leads to rapid neurovascular uncoupling.","volume":"14","author":"Kisler","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1084\/jem.20181035","article-title":"3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice.","volume":"216","author":"Lazic","year":"2019","journal-title":"J. Exp. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1161\/01.CIR.0000058460.34453.5A","article-title":"Protein S confers neuronal protection during ischemic\/hypoxic injury in mice.","volume":"107","author":"Liu","year":"2003","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/0271678X17743670","article-title":"Experimental chronic cerebral hypoperfusion results in decreased pericyte coverage and increased blood-brain barrier permeability in the corpus callosum.","volume":"39","author":"Liu","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"7479","DOI":"10.2174\/1381612819666131230131454","article-title":"Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers.","volume":"19","author":"Lyden","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"B29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ana.25383","article-title":"Final Results of the RHAPSODY trial: a multi-center, phase 2 trial using a continual reassessment method to determine the safety and tolerability of 3K3A-APC, a recombinant variant of human activated protein C, in combination with tissue plasminogen activator, mechanical thrombectomy or both in moderate to severe acute ischemic stroke.","volume":"85","author":"Lyden","year":"2019","journal-title":"Ann. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus.","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"B31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nm.4482","article-title":"Pericyte degeneration causes white matter dysfunction in the mouse central nervous system.","volume":"24","author":"Montagne","year":"2018","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1182\/blood-2004-01-0110","article-title":"Activated protein C variants with normal cytoprotective but reduced anticoagulant activity.","volume":"104","author":"Mosnier","year":"2004","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"33022","DOI":"10.1074\/jbc.M705824200","article-title":"Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions.","volume":"282","author":"Mosnier","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1160\/TH14-05-0448","article-title":"Cytoprotective-selective activated protein C therapy for ischaemic stroke.","volume":"112","author":"Mosnier","year":"2014","journal-title":"Thromb. Haemost."},{"key":"B36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fnagi.2020.00108","article-title":"Channelrhodopsin excitation contracts brain pericytes and reduces blood flow in the aging mouse brain in vivo.","volume":"12","author":"Nelson","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41593-019-0434-z","article-title":"Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss.","volume":"22","author":"Nikolakopoulou","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0176225","DOI":"10.1371\/journal.pone.0176225","article-title":"Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-\u03b2 signaling.","volume":"12","author":"Nikolakopoulou","year":"2017","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40478-019-0676-8","article-title":"Mural cell-derived laminin-\u03b15 plays a detrimental role in ischemic stroke.","volume":"7","author":"Nirwane","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2174\/1570159X18666200528143301","article-title":"The stroke-induced blood-brain barrier disruption: current progress of inspection technique, mechanism, and therapeutic target.","volume":"18","author":"Okada","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1161\/STROKEAHA.118.020124","article-title":"Loss of regulator of G-protein signaling 5 leads to neurovascular protection in stroke.","volume":"49","author":"\u00d6zen","year":"2018","journal-title":"Stroke"},{"key":"B43","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature05193","article-title":"Bidirectional control of CNS capillary diameter by pericytes.","volume":"443","author":"Peppiatt","year":"2006","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"8990","DOI":"10.1096\/fj.201900153R","article-title":"Regulator of G-protein signaling 5 regulates the shift from perivascular to parenchymal pericytes in the chronic phase after stroke.","volume":"33","author":"Roth","year":"2019","journal-title":"FASEB J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2015.09.025","article-title":"Shedding of soluble platelet-derived growth factor receptor-\u03b2 from human brain pericytes.","volume":"607","author":"Sagare","year":"2015","journal-title":"Neurosci. Lett."},{"key":"B46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/bpa.12004","article-title":"Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer\u2019s disease.","volume":"23","author":"Sengillo","year":"2013","journal-title":"Brain Pathol. Zurich Switz."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e12773","DOI":"10.1172\/jci.insight.127736","article-title":"Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons.","volume":"5","author":"Shi","year":"2019","journal-title":"JCI Insight"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1182\/blood-2017-10-810895","article-title":"PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke.","volume":"131","author":"Sinha","year":"2018","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","article-title":"The role of brain vasculature in neurodegenerative disorders.","volume":"21","author":"Sweeney","year":"2018","journal-title":"Nat. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back.","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10456-021-09796-4","article-title":"Pericyte hypoxia-inducible factor-1 (HIF-1) drives blood-brain barrier disruption and impacts acute ischemic stroke outcome.","volume":"24","author":"Tsao","year":"2021","journal-title":"Angiogenesis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.brainres.2010.05.075","article-title":"Activated protein C analog with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact.","volume":"1347","author":"Walker","year":"2010","journal-title":"Brain Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1161\/STROKEAHA.108.536680","article-title":"Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity.","volume":"40","author":"Wang","year":"2009","journal-title":"Stroke"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1161\/STROKEAHA.112.658997","article-title":"An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents.","volume":"43","author":"Wang","year":"2012","journal-title":"Stroke"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1161\/STROKEAHA.113.003350","article-title":"Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats.","volume":"44","author":"Wang","year":"2013","journal-title":"Stroke"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.2174\/138161212802430413","article-title":"Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke.","volume":"18","author":"Williams","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"B57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","article-title":"Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis.","volume":"125","author":"Winkler","year":"2013","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/nm.2022","article-title":"Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery.","volume":"15","author":"Yemisci","year":"2009","journal-title":"Nat. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.celrep.2018.12.055","article-title":"TRIM9-mediated resolution of neuroinflammation confers neuroprotection upon ischemic stroke in mice.","volume":"27","author":"Zeng","year":"2019","journal-title":"Cell Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12975-019-00711-0","article-title":"Activation of sigma-1 receptor enhanced pericyte survival via the interplay between apoptosis and autophagy: implications for blood-brain barrier integrity in stroke.","volume":"11","author":"Zhang","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier.","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1172\/JCI38476","article-title":"Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells.","volume":"119","author":"Zhong","year":"2009","journal-title":"J Clin Invest"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1182\/blood-2010-01-262386","article-title":"Protein S controls hypoxic\/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.","volume":"115","author":"Zhu","year":"2010","journal-title":"Blood"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.841916\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T08:05:49Z","timestamp":1648627549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.841916\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":63,"alternative-id":["10.3389\/fnins.2022.841916"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.841916","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"article-number":"841916"}}